| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |